ABL
Biotechnology ResearchMaryland, United States201-500 Employees
ABL is a mid-sized biotechnology research firm based in Rockville, Maryland, with a history spanning more than six decades serving the life sciences sector. Founded in 1961 as a biomedical research contractor for the federal government, the company has contributed to the development and evaluation of diagnostics, vaccines, and therapeutics. It offers core capabilities in product development, GMP manufacturing, and analytical testing, partnering with clients to advance candidate vaccines and therapies through preclinical and clinical development. The firm's contract development and manufacturing organization division focuses on GMP cell bank and viral vector development and manufacturing, supporting work from bench to Phase I/II trials. Its CDMO services cover bulk drug substance production, fill/finish, process development, and assay development and release testing, with a focus on innovations in gene therapies, immunotherapies, viral vaccines, and oncolytic viruses. With facilities in the United States, ABL aims to act as a seamless extension of its clients’ teams to help translate ideas into tomorrow’s medicines.